Cargando…
FH535 Inhibited Migration and Growth of Breast Cancer Cells
There is substantial evidence indicating that the WNT signaling pathway is activated in various cancer cell types including breast cancer. Previous studies reported that FH535, a small molecule inhibitor of the WNT signaling pathway, decreased growth of cancer cells but not normal fibroblasts, sugge...
Autores principales: | Iida, Joji, Dorchak, Jesse, Lehman, John R., Clancy, Rebecca, Luo, Chunqing, Chen, Yaqin, Somiari, Stella, Ellsworth, Rachel E., Hu, Hai, Mural, Richard J., Shriver, Craig D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439405/ https://www.ncbi.nlm.nih.gov/pubmed/22984505 http://dx.doi.org/10.1371/journal.pone.0044418 |
Ejemplares similares
-
DNA Aptamers against Exon v10 of CD44 Inhibit Breast Cancer Cell Migration
por: Iida, Joji, et al.
Publicado: (2014) -
FH535 inhibited metastasis and growth of pancreatic cancer cells
por: Wu, Meng-Yao, et al.
Publicado: (2015) -
Inhibition of cancer cell growth by ruthenium complexes
por: Iida, Joji, et al.
Publicado: (2016) -
FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases
por: Gustafson, Carl T., et al.
Publicado: (2017) -
FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis
por: Liu, Lu, et al.
Publicado: (2016)